Francesco Maria Lavino, Chief Commercial Officer at Nabriva Therapeutics plc (NBRV), bought 2,160 shares at $4.60 ($10K) on 2018-05-23, disclosed to the SEC on 2018-05-29.
Open-market purchase of $10k NBRV by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |